Jose Ledezma, MD
Family Medicine · Edinburg, TXNPI 1245641257
Payments from drug & device makers
Across 201 payments — averaging $1490.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$156K
- CSL Plasma Inc.$143K
- Otsuka America Pharmaceutical, Inc.$112
- Corium, LLC$79
- Teva Pharmaceuticals USA, Inc.$68
- Ironshore Pharmaceuticals Inc.$38
- plus $170 from 8 others
What the payments were for
- Consulting fees$299,185100%
- Food & beverage$4670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 94 | $155,870 |
| CSL Plasma Inc. | 82 | $143,315 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| Corium, LLC | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
How this compares
$299,652 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $45,394 |
| JardianceEmpagliflozin | 17 | $15,882 |
| LinzessLinaclotide | 17 | $9,559 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $6,795 |
| Atorvastatin Calcium | 152 | $1,489 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,276 |
| Metformin Hcl | 75 | $711 |
| Fluconazole | 17 | $677 |
| Losartan Potassium | 35 | $595 |
| Colchicine | 12 | $498 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $497 |
| Pantoprazole Sodium | 31 | $484 |
| Gabapentin | 33 | $469 |
| Lisinopril | 51 | $443 |
| Bumetanide | 13 | $343 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Edinburg
- Ashley BoseEdinburg$2.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.